Naoya Nagamine

Director, Oncology Business Unit

Naoya Nagamine

High quality without burdening our clients

High quality without burdening our clients

Ever since Linical started offering clinical development support in the area of oncology in 2010, it has grown rapidly, to the point that oncology is now the strongest focus of clinical operations. This is entirely due to the patronage of our clients, to whom we feel very grateful.
To continue meeting our clients’ expectations, we consider ourselves their development partners, actively submitting proposals based on our accumulated experience. In addition, by sharing information across projects, and formulating and executing CAPAs (Corrective and Preventive Actions) promptly and appropriately, we can effectively handle multiple trials for clients, without unduly burdening them and without compromising our high quality standards.

Through our determined approach and implementing systems that lead to successful trials, we have accumulated a high degree of expertise in various kinds of carcinoma (solid cancers, blood cancers, supportive care) across different trial phases, as well as in relation to cancer immunotherapy, an area that is now the focus of much attention. Furthermore, we are also engaging in more and more Japan-led global trials each year.
In this way, Linical’s Oncology Business Unit has already accumulated a broad body of experience, which continues to grow rapidly. So, when you are considering selecting a contractor to conduct a clinical trial, please feel free to contact us. We are at your disposal to offer proposals that can genuinely meet your needs and we will do our best to satisfy your every requirement.